findmyKOL
Clinical trialNCT06240455SuspendedPhase 2Interventional

Phase 2 Study to Assess Efficacy & Safety of WP1302 Prevent Relapse of MMI w/Draw in Subj. w/ Graves' dz

SponsorWorg Biotherapeutics Inc.Enrollment176Graves Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • East Valley Diabetes and Endocrinology-Clinical Research, Pllc

    Hunt, Arizona, United States

  • Alliance Research Institute

    Canoga Park, California, United States

  • Paradigm Clinical Research Centers - Littleton

    Littleton, Colorado, United States

  • Baycare Health System, Inc.

    Clearwater, Florida, United States

  • Albuquerque Clinical Trials Inc

    Albuquerque, New Mexico, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Clinical Research Solution Llc Dba Endocrine and Psychiatry Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2026
Primary completion
31 Mar 2029
Completion
30 Sept 2030
Last update posted
8 May 2025
Registered enrollment
176
Registry id
NCT06240455

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.